From promising drug development, diagnosis of genetic disease, and the realization of personalized medicine, the exciting possibilities behind genomics and bioinformatic research are as vast as they are life changing. These medical advances are based on the ability of modern biotech and pharma companies to analyze terabytes of genomic data using bioinformatics pipelines – the sequencing of multiple pieces of distinct code. Almaden Genomics’ cloud-native bioinformatics platform is condensing what has taken months to mere hours – accelerating genomic discovery and delivering health benefits to us all.
With the g.nome™ platform, long-time barriers linked to workflow language, process flow visibility and quality control are removed. All that’s left are streamlined, scalable and interoperable genomic workflows — leaving research teams to do what they do best: focus on the science.
ALMADEN GENOMICS’ DEVELOPMENT TIMELINE
Project Gnome Founded as an Incubator
Project gnome’s core team wins internal startup funding competition at Fortune 50 company with a revolutionary approach to bioinformatics and accelerates development of g.nome™ platform.
First Prototype of g.nome™ Developed
Within 12 months, graphical workflow builder and cloud execution engine prototype is built. Team grows significantly to include talented bioinformaticians, scientists and engineers.
First Pilot Customer
At beta release, project team formally rebrands itself to Almaden Genomics and secures its first two pilot customers, who see immediate benefits to throughput by using the platform.
First Customer Agreement
First customer validates g.nome’s value propositions into the commercial biotech market.
Definitive Agreement with Founding Company